Opening Ceremony at SOLACI-CACI 2017 Congress

The largest Interventional Cardiology Congress in Latin America has already started. At Pacífico Room, Hilton Buenos Aires Hotel, the Scientific and Organizing Committee presented the objectives and contents for the next three intense days of scientific activity.

Opening Ceremony at SOLACI-CACI 2017 Congress
The first Congress activity was an international joint session with TCT.

The first Congress session was an international joint session with TCT.

 

Congress President Dr. Ruben Piraino highlighted the registration record of over 3000 attendees from all over the world. He also mentioned the 450 faculty members (425 from Latin America and 25 international guests) involved in the event and the 10 live cases, the 8 edited cases, round tables, lunch symposiums, and more, as the main attractions in this “unforgettable event.”

 

Dr. Fernando Cura and Dr. Alberto Sampaolesi (from the Scientific Committee) talked about a “need for a different kind of event, given the disparateness within the scientific audience, composed by both novice professionals and true experts in the field.” They also emphasized the crucial support received from the industry, without which no event of this magnitude could have been pulled off. Furthermore, they expressed their hope that “this work will result in growth for this specialty in this geographical region, higher benefits for patients, and, above all, an increase in the quality of cardiovascular health.”

 

SOLACI President Dr. Ricardo Lluberas mentioned that “the work carried out by the Scientific and Organizing Committee throughout this year was absolutely self-sacrificing. In consequence, once this Congress is over and we return to our homes, we will surely bring with us satisfaction derived from the fact that SOLACI-CACI 2017 will have effectively contributed to the strengthening of interventional cardiology in Latin America.”


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Hemodynamic Outcomes of Edge-to-Edge Repair in Degenerative and Functional Mitral Regurgitation

Transcatheter edge-to-edge mitral valve repair (M-TEER) has become an established therapeutic option for mitral valve disease. Among the available techniques, M-TEER using the MitraClip...

Institutional Statement: SOLACI Expresses Its Solidarity with the People of Venezuela

The Latin American Society of Interventional Cardiology (SOLACI) expresses its deepest sorrow over the consequences of the earthquake that has affected Venezuela. We stand in...

SAPIEN 3 TAVI Durability: Ten-Year Follow-Up in Intermediate-Risk Patients

The durability of transcatheter bioprosthetic valves used in TAVI remains one of the key unanswered questions as indications continue to expand toward patients with...

Inflammation after TAVI: An Emerging Therapeutic Target?

Conduction disturbances and the need for permanent pacemaker implantation remain common complications following TAVI, with an incidence approaching 15%. Although they have traditionally been...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

Is IVUS Always Necessary for Left Main Coronary Artery PCI?

Percutaneous coronary intervention (PCI) of the unprotected left main coronary artery is a highly complex procedure because of the large amount of myocardium at...

Dual-Prep Registry: Atherectomy and IVL for Severe Coronary Calcification

Severe coronary calcification remains one of the most challenging scenarios in percutaneous coronary intervention (PCI). Although rotational or orbital atherectomy and intravascular lithotripsy (IVL)...

Hemodynamic Outcomes of Edge-to-Edge Repair in Degenerative and Functional Mitral Regurgitation

Transcatheter edge-to-edge mitral valve repair (M-TEER) has become an established therapeutic option for mitral valve disease. Among the available techniques, M-TEER using the MitraClip...